Possibilities of the tolerance development to nipradilol and of the measurement of vascular glutathione content in isolated rat aorta.

[1]  T R Miller,et al.  Principles of therapeutics. , 1992, The Veterinary clinics of North America. Equine practice.

[2]  C. Twort,et al.  Cyclic Guanosine Monophosphate‐Enhanced Sequestration of Ca2+ by Sarcoplasmic Reticulum in Vascular Smooth Muscle , 1988, Circulation research.

[3]  J. Abrams.  Tolerance to organic nitrates , 1986, Circulation.

[4]  R. Rapoport.  Cyclic Guanosine Monophosphate Inhibition of Contraction May be Mediated through Inhibition of Phosphatidylinositol Hydrolysis in Rat Aorta , 1986, Circulation research.

[5]  C. A. Gruetter,et al.  Dissociation of cysteine and glutathione levels from nitroglycerin-induced relaxation. , 1985, European journal of pharmacology.

[6]  M. Hinescu,et al.  The mechanism of cGMP-induced relaxation in vascular smooth muscle. , 1985, European journal of pharmacology.

[7]  L. Ignarro,et al.  The pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation. , 1985, Annual review of pharmacology and toxicology.

[8]  W. Kukovetz,et al.  Mechanisms of nitrate-induced vasodilatation and tolerance on a biochemical base. , 1985, Zeitschrift fur Kardiologie.

[9]  M. Krüpe,et al.  [Specificity and normality of peripheral systolic pressure measurement by the ultrasound Doppler technic in healthy angiography-imaged extremities]. , 1985, Zeitschrift fur Kardiologie.

[10]  S. Takeo,et al.  Effects of an antihypertensive agent, nipradilol, on isolated coronary artery of the dog. , 1984, Pharmacology.

[11]  S. Imai,et al.  Beta-receptor blocking potencies of the three newly synthesized beta-adrenergic antagonists (S-596, K-351, N-696) as assessed with the radioligand binding assay method in rat cardiac muscle membrane treated with neuraminidase. , 1984, Japanese journal of pharmacology.

[12]  S. Vatner,et al.  Mechanism of Constriction of Large Coronary Arteries by Adrenergic Receptor Blockade , 1983, Circulation research.

[13]  J. Abrams.  Nitroglycerin and long-acting nitrates in clinical practice. , 1983, The American journal of medicine.

[14]  H. Suzuki,et al.  The effects of 3,4‐dihydro‐8‐(2‐hydroxy‐3‐isopropylaminopropoxy)‐3‐nitroxy‐2H‐1‐benzopyr an (K‐351) and its denitrated derivative on smooth muscle cells of the dog coronary artery , 1983, British journal of pharmacology.

[15]  Y. Uchida.  Cardiovascular effect of [3,4-dihydro-8-(2-hydroxy-3-isopropylaminopropoxy)-3-nitrato-2H-1-benzopyran] (K 351). , 1982, Japanese heart journal.

[16]  W. Vaughn,et al.  Exacerbation of Vasotonic Angina Pectoris by Propranolol , 1982, Circulation.

[17]  L. Ignarro,et al.  Methylene blue inhibits coronary arterial relaxation and guanylate cyclase activation by nitroglycerin, sodium nitrite, and amyl nitrite. , 1981, Canadian journal of physiology and pharmacology.

[18]  L. Ignarro,et al.  Requirement of thiols for activation of coronary arterial guanylate cyclase by glyceryl trinitrate and sodium nitrite: possible involvement of S-nitrosothiols. , 1980, Biochimica et biophysica acta.

[19]  D. J. Reed,et al.  High-performance liquid chromatography analysis of nanomole levels of glutathione, glutathione disulfide, and related thiols and disulfides. , 1980, Analytical biochemistry.

[20]  J Abrams,et al.  Nitrate tolerance and dependence. , 1980, American heart journal.

[21]  R. Zelis,et al.  Isosorbide dinitrate. Effect on the vasodilator response to nitroglycerin. , 1975 .

[22]  P. Needleman,et al.  Mechanism of tolerance development to organic nitrates. , 1973, The Journal of pharmacology and experimental therapeutics.